Research on the policy evolution and knowledge graph of biomedical industry in the Chengdu-Chongqing economic circleLIU Yi-ling, ZHENG Ying2537-2545
Myasthenia gravis treatment drug:zilucoplanLIU Shuang, LIU Chang, JIANG Dan-qin, SU Chang, TANG Yi-nan2546-2549
Registration management of post-approval changes of production site of biological drug substance in ChinaJIANG Dan-li, LIN Lin, TIAN Li-juan2550-2554
The therapeutic effect of koumine on acute liver injury in mice with sepsis and its mechanismsHUANG Hui-hui, LUO Yu-fei, CHEN Jin-xing, JIN Gui-lin, YU Chang-xi, YANG Jian2555-2561
Adeno-associated virus vector-based gene therapy:clinical use and safety informationZHANG Jing-ye, ZHUO Yang, YU Jia-ning, ZHOU Long-rui, CHEN Yi-fei2562-2567
Retrospective analysis of death cause in clinical cases of adeno-associated virus gene therapy productsZHANG Yan-mei, ZHAO Xiao-dong, ZHOU Chang-hui, LI Hua2568-2574
Research progress of omadacycline in the treatment of Mycobacterium abscessus pulmonary diseaseWANG Qian, LIANG Pei, LAN Chen, YAN Xiao-di, YUAN Bin-bin, LI Li2575-2581
Effect of ciprofol on embolization of cerebral aneurysms in elderly patientsLIU Jing-han, WANG Yuan-yuan2582-2586
An investigation of commercial insurance implementation in clinical trials in ChinaWANG Jia-qing, FENG Bao-yu, XU Shu-hong, FANG Zhao-hui, BAI Cai-zhen, WANG Wei-cong, XU Chun-min, LI Shu-ya2587-2593
Construction of clinical research coordinator position competence model under new circumstancesCHEN Na, CAI Xue-ling, ZOU Yan-lin, ZOU Yan-qin, QIAN Yi2594-2601